| |
|
池田 康夫 |
早稲田大学 特命教授 |
| 血栓止血学 |
Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N.
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
JAMA. 2014 Dec 17;312(23):2510-20. doi: 10.1001/jama.2014.15690.
|
Ikeda Y, Miyakawa Y: Development of thrombopoietin receptor agonists for clinical use.
J Thromb Haemost 7, 239-244, Sup1, 2009
Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., Ambo, H., Kawai, Y., Watanabe, K., Itagaki, I., Sakai, K., and Ruggeri, Z.M.:
|
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
J. Clin. Invest. 87: 1234-1240, 1991
|
|
| |
|
内野 克喜 |
東京薬科大学 常務理事・特命教授 |
| 医療薬学 |
Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and liver cirrhotic patients.
Uchino K, Isozaki S, Amano J, Tanaka N, Saitoh Y, Nakagawa F,Tamura Z. J. Pharm. Dyn. 1983; 6: 684-691.
|
| 第十一改正調剤指針、増補版 日本薬剤師会編 内野克喜（分担） 薬事日報社（2002） |
| 今日の治療指針 2015年版 医学書院 (2015） |
|
| |
|
長野 哲雄 |
東京大学創薬機構 拠点代表者 |
| 薬学 |
Fluorescent probes for sensing and imaging
Ueno, T, and Nagano, T, Nat. Methods, 8, 642-645, 2011.
|
Bioimaging of nitric oxide
Nagano, T, and Yoshimura, T, Chem. Rev., 102, 1235-1269, 2002.
|
Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins
Kojima, H, Nakatsubo, N, Kikuchi, K, Kawahara, S, Kirino, Y, Nagoshi, N, Hirata, Y, and Nagano, T, Anal. Chem., 70, 2446-2453, 1998
|
|
| |
|
埜中 征哉 |
国立精神・神経センター病院 名誉院長 |
| 神経内科学 |
Distal myopathy in multi-minicore disease
Mitsuhashi S, Nonaka I, Wu S, Moreno CA, Shalaby S, Hayashi YK, Noguchi S, Nishino I, Intern Med. 2009;48:1759-62.
|
Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy
Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I, J Clin Invest. 2009;119:2623-33
|
Autophagic degradation of nuclear components in mammalian cells
Park YE, Hayashi YK, Bonne G, Arimura T, Noguchi S, Nonaka I, Nishino I, Autophagy. 2009;5:795-804.
|
|
| ○ |
|
橋田 充 |
京都大学高等研究院 特定教授 |
| 薬物動態学、製剤学 |
Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling
Babazada H, Yamashita F, and Hashida M: J Control Release. 2014; 194: 295-300
|
Ultrasound induced cancer immunotherapy
Unga J and Hashida M. Adv Drug Deliv Rev. 2014; 72: 144-153
|
| 「図解で学ぶDDS−薬物治療の最適化を目指す先端創薬技術 第２版」橋田 充 監修・分担執筆、じほう (2016). |
|
| |
|
安原 一 |
（公財）昭和大学医学・医療振興財団 常務理事 |
| 臨床薬理学 |
Membrane effects of various drugs on isolated rat hepatocytes and erythrocytes.
Yasuhara H, Yonooka M, Kamei K, Sakamoto K. Toxicol Appl Pharmacol. 1985;79:453-460.
|
Which is more important in pharmacokinetics: Inter-ethnic or Intra-ethnic variability? Session 4: Ethnic factors in acceptability of foreign data.
Yasuhara H. Proceeding of The Second International Conference on Harmonization, 436-443, The Queen’s University of Belfast (Northern Ireland) , 1994
|
| 「臨床薬理学」第３版 安原 一他共編 医学書院（２０１１） |
|
